| Serial Number | 78892726 |
| Word Mark | LABORATOIRE KOCH |
| Filing Date | Thursday, May 25, 2006 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, November 22, 2013 |
| Registration Number | 3231979 |
| Registration Date | Tuesday, April 17, 2007 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Disclaimer with Predetermined Text | "Laboratiore" |
| Goods and Services | all purpose disinfectants, anti-arthritic compositions and preparations; anti-bacterial cleaners; anti-cancer preparations; anti-diabetic pharmaceuticals; anti-diabetic preparations; anti-infective products for veterinary use; anti-infectives; anti-inflammatories; anti-inflammatory and antipyretic preparations; anti-sarcoma preparations; antiallergic medicines; antiarrhythmics; antihistamines; antihypertensives; antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; antimicrobials for dermatologic use; antiparasitics; antiseptics; antivirals; appetite suppressants; astringents; astringents for medicinal purposes; bacterial and bacteriological preparations for medical or veterinary purposes; bacteriostats for medicinal, dental and veterinary use; barrier lotion for protection from toxic oils of poisonous plants; beta blockers; biochemical preparations for medical or veterinary purposes; biocides; biological and chemical preparations and reagents for medical or veterinary use; biological implants, namely, avital processed human or animal connective tissue; biological preparations for medical purposes; biological skin and bone tissue intended for subsequent implantation; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; blood plasma; blood substitute for human use; bronchial dilators; bronchodilators; burn relief medication; calcium channel blockers; calcium supplements; cardiovascular pharmaceuticals; cardiovascular treatment preparations; cells for medical or clinical use; central nervous system stimulants; chemical preparations for sanitary purposes; chemical preparations for sanitary use; chemically treated papers for use in the detection of fecal occult blood; chemotherapeutics; chloramphenicol preparations; cholesterol reducers; chondroitin preparations; cleansing solutions for medical use; clinical medical reagents; confectionery for medicinal purposes; dermatological pharmaceutical products; dermatologicals; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for medicinal use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; ferments for medical or veterinary use; fever blister treatment preparations; food supplements; food supplements, namely, anti-oxidants; gastro-intestinal treatment preparations; gelatin capsules sold empty for pharmaceuticals; glaucoma agents; hormones; hormones for medical purposes; human allograft tissue; human growth hormone; hydrocortisone; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; injectable pharmaceuticals for treatment of anaphylactic reactions; insulin; media for bacteriological cultures; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic test strips for use in the field of infectious disease, cancer detection and cancer markers; medical diagnostic test strips for use in the field of protein and nucleic acid detection; medical diagnostic test strips for use in conducting sterility tests; medical diagnostic test strips, namely pH test papers used to measure glucose levels and for use in testing acidity levels of bodily fluids; medicines for the treatment of gastrointestinal diseases; methionine preparations; microbiocides for industrial and institutional manufacturing processes and wastewater applications; mineral supplements; mixed antibiotic preparations; mixed vitamin preparations; multi-vitamin preparations; multivitamin preparations; nucleic acid sequences and chemical reagents for medical and veterinary purposes; nutritive substances for micro-organisms for medical use; nutritive substances for microorganism cultures; nutritive substances for microorganisms for medical purposes; oral spray for the cessation of smoking; oxygen for medical use; pancreas hormone preparations; parapharmaceutical products for use in dermatology; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations namely, anticoagulants; pharmaceutical preparations namely,antidepressants; pharmaceutical preparations namely,appetite suppressants; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; pharmaceuticals, namely, psychotropics; pituitary hormone preparations; plant extracts for medical, veterinary and pharmaceutical purposes; potassium preparations for pharmaceutical purposes; preparation for the relief of pain; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutation in prion genes for medical purposes; preparations for killing weeds; preparations for protecting plants against pathogens; preparations for the suppression of hormones; preparations for the treatment of asthma; processed food adapted for medical purposes; processed human donor skin for the replacement of soft tissue; products and preparations for cleansing the skin for medical use; propolis for medicinal or therapeutic purposes; psychotropics; radiation sickness treating agents; radio-isotope markers for therapeutic or diagnostic use; reagents for medical use; rubbing compound for medical and/or therapeutic use; salivary gland hormone preparations; sanitary preparations for medical use; sanitary sterilising preparations; sanitary sterilizing preparations; sanitizers for hospital use; sanitizers for household use; sanitizers for use in institutional and industrial areas; sanitizing wipes; smoking cessation preparations; steroids; streptomycin preparations; synthetic cholesterol mainly for use in growing cell cultures; synthetic narcotics; synthetic peptides for pharmaceutical purposes; tapes for varicose veins; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; tetracycline preparations; thiolutin preparations; threonine preparations; thyroid and para-thyroid hormone preparations; topical analgesics; topical anesthetics; transdermal patches for use in the treatment of smoking; trichomycin preparations; tryptophane preparations; tumor suppressing agents; vaccine adjuvants; vaccine stabilizers; vaccines; vaccines against flu; vaccines against pneumococcal infections; vascular grafts; vasoconstrictors; vitamin and mineral preparations for medical use; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; vitamin and mineral supplements; vitamin b preparations; vitamin c preparations; vitamin d preparations; vitamin drops; vitamin enriched water; vitamin fortified beverages; vitamin preparations; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; vitamin supplements; vitamin tablets; vitamins; yeast or yeast extracts for medical, veterinary or pharmaceutical purposes |
| Goods and Services | scientific and technological services, namely the research and development of preventative diagnostic services in the field of the detection of cancer and cancer markers; research and development of products, diagnostics or therapeutic methods in the fields of industry, science, medicine, pharmaceuticals, biology, molecular biology, molecular computing, cancer prevention, risk identification and treatment, gene therapy, biotechnology, cell biology, biological markers, genomics and bioanalysis |
| Translation of Words in Mark | The foreign wording in the mark translates into English as laboratory. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 22, 2013 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 22, 2013 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Laboratoire Koch SA |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Lausanne 1000 CH |
| Party Name | Laboratoire Koch SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lausanne 1000 CH |
| Event Date | Event Description |
| Friday, November 22, 2013 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, April 17, 2007 | REGISTERED-SUPPLEMENTAL REGISTER |
| Friday, March 2, 2007 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, March 2, 2007 | ASSIGNED TO LIE |
| Monday, January 29, 2007 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| Monday, January 29, 2007 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 29, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 29, 2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 10, 2007 | PRIORITY ACTION E-MAILED |
| Wednesday, January 10, 2007 | PRIORITY ACTION WRITTEN |
| Friday, January 5, 2007 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 5, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 5, 2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 27, 2006 | NON-FINAL ACTION E-MAILED |
| Friday, October 27, 2006 | NON-FINAL ACTION WRITTEN |
| Friday, October 27, 2006 | NON-FINAL ACTION E-MAILED |
| Friday, October 27, 2006 | NON-FINAL ACTION WRITTEN |
| Thursday, October 26, 2006 | ASSIGNED TO EXAMINER |
| Friday, June 2, 2006 | NEW APPLICATION ENTERED IN TRAM |